Development of a Locus-specific qPCR-HRM Method for DNA Methylation Analysis of the SHANK3 Gene

Sema Tiryaki

doi:10.31067/acusaglik.1800190

Development of a Locus-specific qPCR-HRM Method for DNA Methylation Analysis of the SHANK3 Gene

Abstract

Purpose: DNA methylation within CpG islands is a major epigenetic mechanism regulating gene expression. SHANK3 encodes a synaptic scaffolding protein essential for neurodevelopment and synaptic function, and its aberrant methylation has been implicated in neuropsychiatric disorders. This study aimed to develop a reliable locus-specific high-resolution melting (HRM) assay for the analysis of SHANK3 methylation. Methods: In silico CpG island analysis identified a CpG-rich region upstream of exon 3 as a suitable locus for primer design. Bisulfite-converted fully methylated and unmethylated control DNAs were used to generate and test three primer sets. HRM assays were optimized and validated on two real-time PCR platforms (LightCycler® 480 and CFX96). Conversion efficiency and amplification specificity were confirmed using commercial methylated and unmethylated DNA controls. Results: Two primer sets successfully amplified the target region and produced distinct melting profiles, enabling clear discrimination between methylated and unmethylated templates. The assay demonstrated high reproducibility and consistent melting pattern separation across platforms. Conclusion: This locus-specific HRM assay provides a robust and cost-effective approach for qualitative analysis of SHANK3 DNA methylation. It offers a methodological basis for future validation studies and potential clinical investigations of epigenetic dysregulation in neurodevelopmental and neuropsychiatric disorders.

Keywords

Ethical Statement

Ethical approval was not required for this study, as it did not involve human participants, animal subjects, or patient data.

Thanks

The author gratefully acknowledges the Bioanalysis Laboratory at TÜBİTAK UME for providing the facilities and resources that made this work possible.

References

1. Geissler F, Nesic K, Kondrashova O, et al. The role of aberrant DNA methylation in cancer initiation and clinical impacts. Ther Adv Med Oncol.2024;16:17588359231220511. DOI:10.1177/17588359231220511.
2. Wajed SA, Laird PW, DeMeester TR. DNA Methylation: An Alternative Pathway to Cancer. Ann Surg. 2001;234:10-20. DOI:10.1097/00000658200107000-00003.
3. Leung WK, To KF, Chu ESH, et al. Potential diagnostic and prognostic values of detecting promoter hypermethylation in the serum of patients with gastric cancer. Br J Cancer. 2005;92:2190–2194. DOI:10.1038/sj.bjc.6602636.
4. Müller D, Győrffy B. DNA methylation-based diagnostic, prognostic, and predictive biomarkers in colorectal cancer. Biochim Biophys Acta Rev Cancer. 2022;1877:188722. DOI:10.1016/j. bbcan.2022.188722.
5. Locke WJ, Guanzon D, Ma C, et al. DNA Methylation Cancer Biomarkers: Translation to the Clinic. Front Genet. 2019;10:1150. DOI:10.3389/fgene.2019.01150.
6. Mikeska T, Craig JM. DNA Methylation Biomarkers: Cancer and Beyond. Genes (Basel).2014;5:821-864. DOI:10.3390/ genes5030821.
7. Brenet F, Moh M, Funk P, et al. DNA methylation of the first exon is tightly linked to transcriptional silencing. PLoS One. 2011;6:e14524. DOI:10.1371/journal.pone.0014524.
8. Li S, Zhang J, Huang S, et al. Genome-wide analysis reveals that exon methylation facilitates its selective usage in the human transcriptome. Brief Bioinform. 2018;19:754–764. DOI:10.1093/bib/ bbx019.

9. Maunakea AK, Chepelev I, Cui K, et al. Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition. Cell Res. 2013;23:1256–1269. DOI:10.1038/ cr.2013.110.
10. Gelfman S, Cohen N, Yearim A, et al. DNA-methylation effect on cotranscriptional splicing is dependent on GC architecture of the exon–intron structure. Genome Res. 2013;23:789-799. DOI:10.1101/ gr.143503.112.
11. Monteiro P, Feng G. SHANK proteins: roles at the synapse and in autism spectrum disorder. Nature Reviews Neuroscience 2017 18:3 2017;18:147–157. DOI:10.1038/nrn.2016.183.
12. Jiang Y hui, Ehlers MD. Modeling Autism by SHANK Gene Mutations in Mice. Neuron. 2013;78:8. DOI:10.1016/j.neuron.2013.03.016.
13. Durand CM, Betancur C, Boeckers TM, et al. Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nature Genetics. 2006 39:1 2006;39:25–27. DOI:10.1038/ng1933.
14. Zhu L, Wang X, Li XL, et al. Epigenetic dysregulation of SHANK3 in brain tissues from individuals with autism spectrum disorders. Hum Mol Genet. 2014;23:1563–1578. DOI:10.1093/hmg/ddt547.
15. Nardone S, Sharan Sams D, Reuveni E, et al. DNA methylation analysis of the autistic brain reveals multiple dysregulated biological pathways. Translational Psychiatry. 2014 4:9 2014;4:e433–e433. DOI:10.1038/tp.2014.70.
16. Zhou Q, Tian Y, Xu C, et al. Prenatal and postnatal traffic pollution exposure, DNA methylation in SHANK3 and MeCP2 promoter regions, H3K4me3 and H3K27me3 and sociability in rats’ offspring. Clin Epigenetics. 2021;13. DOI:10.1186/S13148-021-01170-x.
17. Maunakea AK, Nagarajan RP, Bilenky M, et al. Conserved role of intragenic DNA methylation in regulating alternative promoters. Nature. 2010 466:7303 2010;466:253–257. DOI:10.1038/ nature09165.
18. Lister R, Mukamel EA, Nery JR, et al. Global epigenomic reconfiguration during mammalian brain development. Science. 2013;341. DOI:10.1126/science.1237905.
19. Hahn Lab utilities. Bisulfite Conversion (web tool). Available from: http://canna.cau.ac.kr/util/ (accessed 27 May 2025).
20. Amplicon3Plus. Amplicon3Plus (web tool). Available from: https:// www.primer3plus.com/amplicon3plus.html. (accessed 27 May 2025).

Details

Primary Language

English

Subjects

Analytical Biochemistry

Journal Section

Research Article

Authors

Sema Tiryaki ^*
0000-0003-2926-5902
Türkiye

Publication Date

March 18, 2026

Submission Date

October 9, 2025

Acceptance Date

January 26, 2026

Published in Issue

Year 2026 Volume: 17 Number: January, February, March 2026

DOI

https://doi.org/10.31067/acusaglik.1800190

IZ

https://izlik.org/JA62YK39FW

Cite

RIS / Bibtex

EndNote

Tiryaki S (March 1, 2026) Development of a Locus-specific qPCR-HRM Method for DNA Methylation Analysis of the SHANK3 Gene. Acıbadem Üniversitesi Sağlık Bilimleri Dergisi 17 January, February, March 2026